NASDAQ: CYPHCypherpunk Technologies Inc Stock Ownership - Who owns Cypherpunk Technologies?
Insider buying vs selling
Have Cypherpunk Technologies Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christopher Mirabelli | Director | 2026-03-26 | 60,000 | $0.71 | $42.66kSell |
| Thomas John Dietz | Director | 2025-12-26 | 35,000 | $1.20 | $42.00kSell |
| James H. Cavanaugh | Director | 2025-11-17 | 261,840 | $3.14 | $822.18kSell |
| Douglas E. Onsi | CEOCFOPres.GCTreas.Sec. | 2025-11-17 | 261,840 | $3.14 | $822.18kSell |
| Douglas E. Onsi | CEOCFOPres.GCTreas.Sec. | 2025-11-17 | 414,479 | $3.14 | $1.30MSell |
| Christopher Mirabelli | Director | 2025-11-17 | 414,479 | $3.14 | $1.30MSell |
| Christopher Mirabelli | Director | 2025-11-17 | 261,840 | $3.14 | $822.18kSell |
CYPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CYPH insiders and whales buy or sell their stock.
CYPH Shareholders
What type of owners hold Cypherpunk Technologies Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 7.87% | 8,476,496 | $5.46M | Insider |
| William Patrick McEvoy Iii | 7.69% | 8,283,761 | $5.33M | Insider |
| Winklevoss Capital Fund LLC | 7.69% | 8,283,761 | $5.33M | Insider |
| Beigene Ltd | 6.82% | 7,348,437 | $4.73M | Insider |
| Gilead Sciences Inc | 4.94% | 5,319,148 | $3.43M | Insider |
| Healthcare Ventures IX LP | 3.85% | 4,144,804 | $2.67M | Insider |
| John W. Littlechild | 2.43% | 2,618,406 | $1.69M | Insider |
| Augustine Lawlor | 1.59% | 1,718,454 | $1.11M | Insider |
| Lilly Co Eli | 1.37% | 1,479,307 | $952.67k | Insider |
| Christopher Mirabelli | 0.82% | 888,745 | $572.35k | Insider |
CYPH vs Biotech Stocks
Cypherpunk Technologies Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.